140866-78-0Relevant articles and documents
Synthesis of constrained 4-(phosphonomethyl)phenylalanine derivatives as hydrolytically stable analogs of O-phosphotyrosine
Liu, Wang-Qing,Carreaux, Francois,Meudal, Herve,Roques, Bernard P.,Garbay-Jaureguiberry, Christiane
, p. 4411 - 4422 (2007/10/03)
In order to elucidate the role of protein tyrosine phosphorylation involved in various intracellular signaling pathways, peptides containing O-phosphotyrosine have been developed. However, in order to improve the stability of the phosphorylation amino acid, we have designed some years ago a hydrolytically stable analogue,the 4-(phosphonomethyl)phenylalanine (Pmp). Introduced in peptide sequences, this residue, which is resistant to phosphatase action, was shown also able to inhibit substrate recognition by protein targets. With the aim to design peptidomimetics endowed with improved affinity and selectivity, we report in this study the synthesis of five new sterically hindered amino acids derived from Pmp. These modifications include α-methyl, β-methyl, β,β-dimethyl substitutions, α,β-cyclization of Pmp and methyl substitution on the phosphonomethyl group of Pmp.
Preparation of an angiotensin i analog containing a p-phosphonomethyl-l-phenylalanine residue via asymmetric synthesis of t-boc-p-dimethylphosphonomethyl-l-phenylalanine
Cushman, Mark,Lee, Eung-Seok
, p. 1193 - 1196 (2007/10/02)
t-BOC-p-Dimethylphoshonomethyl-L-phenylalanine has been prepared and incorporated into a peptide sequence corresponding to angiotensin I. Demethylation of the dimethylphosphonomethyl moiety then yielded a peptide containing a p-phosphonomethyl-L-phenylalanine residue.